is mounjaro a semaglutide drug GLP-1 vs Ozempic vs Wegovy vs Switching Semaglutide to Tirzepatide |

Novo Nordisk, the manufacturer of Rybelsus, failed to properly warn consumers against the risk of gastroparesis and other serious health events related to the drug

Given an established role of GLP-1 receptor agonists (GLP-1 RAs) in reducing body weight in people who are overweight or obese, with or without diabetes [13,14,15,16,17], it is therefore reasonable to question whether any weight-reducing effects of GLP-1 RAs are mediated trough the modulation of gustatory coding

They are also contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, based on preclinical findings in rodent models

Shima Hadidchi explains that Ozempics primary benefit is in its ability to help patients control their appetite and improve blood sugar regulation, which can indirectly affect metabolism by improving glucose processing and reducing insulin resistance